Clinical Trial

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Name: Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation — clinical trial record (NCT07354477)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: (PENGUIN)

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG

Protocol Amendment History 2 changes

notable Primary completion pushed: 2026-06 -> 2026-09 2026-07-07

minor Completion pushed: 2026-06 -> 2026-09 2026-07-07

Trial Details

NCT Number	NCT07354477
Lead Sponsor	Qlaris Bio, Inc.
Conditions	Non-proliferative Diabetic Retinopathy (NPDR), Open-angle Glaucoma (OAG), Normal Tension Glaucoma (NTG)
Enrollment	14 participants
Start Date	2026-02-20
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-06